Search results for "breast neoplasms"

showing 10 items of 804 documents

Breast Cancer Incidence in Palermo City (Italy)

1996

Adultmedicine.medical_specialtyObstetricsbusiness.industryIncidenceGeneral NeuroscienceIncidence (epidemiology)Age FactorsBreast NeoplasmsMiddle Agedmedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyBreast cancerItalyHistory and Philosophy of SciencemedicineHumansFemalebusinessAnnals of the New York Academy of Sciences
researchProduct

Cytogenetics, flow cytometry, cytophotometry and morphometry of 22 cases of primary breast carcinoma. A comparative study.

1992

Cytogenetic, flow cytometric, cytophotometric and morphometric analyses were performed on 22 previously untreated, primary solid breast carcinomas. Although the cell nuclei as the primary object of these studies were the same in all the tumors, distinct features were evaluated in each case to determine to what degree the results obtained by these techniques are comparable. From the cytogenetic viewpoint, six tumors had a modal number in the diploid range, seven were in the triploid range, and two in the tetraploid range; seven tumors had no modal number. These data correlate with the flow cytometry and cytophotometry results obtained, with DNA values slightly higher than their respective ch…

Adultmedicine.medical_specialtyPathologyNuclear areaBreast NeoplasmsBiologyFlow cytometryPolyploidyBreast cancermedicineChromosomes HumanHumansAgedCell NucleusChromosome Aberrationsmedicine.diagnostic_testChromosomes Human Pair 11CarcinomaCytogeneticsDNAMiddle Agedmedicine.diseaseCytophotometryModal NumberChromosome BandingChromosomes Human Pair 1KaryotypingFemalePloidyBreast carcinomaChromosomes Human Pair 16Virchows Archiv. B, Cell pathology including molecular pathology
researchProduct

Uterine leiomyoma metastasis as a first sign of breast cancer

1998

Uterine metastases from extragenital cancer are rarely reported in the literature. More frequently, the female genital tract is involved by direct extension from an adjacent pelvic organ. A 37-year-old woman had a myoma of the uterine wall and hypermenorrhea. The mass was laparoscopically enucleated, and frozen section examination was performed because it was macroscopically suspicious for sarcomatoid degeneration. The final diagnosis was metastatic carcinoma in the uterus of probable breast origin.

Adultmedicine.medical_specialtyPathologyUterusAntineoplastic AgentsBreast NeoplasmsMetastatic carcinomaMetastasisFatal OutcomeBreast cancermedicineHumansGynecologyFrozen section procedureUterine leiomyomaLeiomyomabusiness.industryBiopsy NeedleObstetrics and GynecologyCancerMyomamedicine.diseaseImmunohistochemistrymedicine.anatomical_structureChemotherapy AdjuvantLymphatic MetastasisUterine NeoplasmsFemaleLaparoscopyRadiotherapy AdjuvantbusinessThe Journal of the American Association of Gynecologic Laparoscopists
researchProduct

Preoperative assessment of breast cancer: sonography versus MR imaging.

2002

The purposes of our study were to compare the diagnostic value of whole-breast sonography and MR imaging as adjunctive techniques to mammography and to determine whether MR imaging should be used routinely in the preoperative assessment of patients with suspected breast cancer.. One hundred four women (age range, 34-84 years; mean age, 60 years) with findings highly suggestive of malignancy in the breast were examined with mammography, sonography, and dynamic MR imaging before undergoing surgery. All visualized suspicious lesions were correlated histologically. The diagnostic relevance of sonographic and MR imaging findings was compared with the diagnostic value of the findings of clinical …

Adultmedicine.medical_specialtyPhysical examinationBreast NeoplasmsMalignancyBreast cancermedicineMammographyHumansRadiology Nuclear Medicine and imagingBreastFalse Negative ReactionsAgedAged 80 and overmedicine.diagnostic_testbusiness.industryDiagnostic Tests RoutineMean ageMagnetic resonance imagingGeneral MedicineMiddle Agedmedicine.diseaseMr imagingMagnetic Resonance ImagingInvasive growthFemaleRadiologyUltrasonography MammarybusinessMammographyAJR. American journal of roentgenology
researchProduct

Outcome Analysis and Rational Management of Enhancing Lesions Incidentally Detected on Contrast-Enhanced MRI of the Breast

2003

The purpose of our study was to assess the prevalence, characteristics, and clinical consequence of incidentally detected enhancing lesions on MRI of the breast. SUBJECTS AND METHODS. MRI of the breast (1.0-T scanner, dynamic gadolinium-enhanced T1-weighted three-dimensional gradient-echo sequence, double breast coil) was performed on 1273 women for different indications. Enhancing incidental lesions were defined as enhancing lesions on MRIs that were not expected from findings on the previous conventional imaging. They were classified in five assessment categories using a scoring system based on morphologic and kinetic enhancement characteristics. Detection of enhancing incidental lesions …

Adultmedicine.medical_specialtyScoring systemAdolescentCONTRAST ENHANCED MRIOutcome analysisContrast MediaBreast NeoplasmsOutcome assessmentSeverity of Illness IndexPredictive Value of TestsOutcome Assessment Health CaremedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesProspective cohort studyAgedAged 80 and overIncidental Findingsmedicine.diagnostic_testbusiness.industryFollow up studiesReproducibility of ResultsMagnetic resonance imagingGeneral MedicineMiddle AgedMagnetic Resonance ImagingPredictive value of testsFemaleRadiologybusinessFollow-Up StudiesAmerican Journal of Roentgenology
researchProduct

Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to i…

2014

Background Preoperative lymphoscintigraphy is without doubt a valid method for the detection of the sentinel lymph node (SLN). There has been considerable debate regarding the optimal site for the introduction of the tracer; various sites include peritumoral (PT), periareolar (PA), subdermal, and intradermal injection. Purpose To evaluate retrospectively the lymphoscintigraphic identification rate of peritumoral (PT) injection versus subdermal periareolar (PA) injection in the detection of SLNs in breast cancer. Material and Methods Between October 2002 and December 2011, a cohort of 906 consecutive patients with biopsy proven breast cancer underwent 914 SLN biopsy procedures. A total of 33…

Adultmedicine.medical_specialtySentinel lymph nodechemistry.chemical_elementBreast NeoplasmsInjections IntralesionalTechnetiumPeriareolarBreast cancerBiopsymedicineCarcinomaHumansRadiology Nuclear Medicine and imagingTechnetium Tc 99m Aggregated AlbuminAgedRetrospective StudiesAged 80 and overBreast cancer sentinel lymph node biopsy lymphoscintigraphy sub areolar peritumoral radio-colloidRadiological and Ultrasound Technologymedicine.diagnostic_testSentinel Lymph Node Biopsybusiness.industryHuman albuminGeneral MedicineMiddle AgedImage Enhancementmedicine.diseaseSurgerychemistryFemaleLymphRadiopharmaceuticalsSettore MED/36 - Diagnostica Per Immagini E RadioterapiaNuclear medicinebusinessLymphoscintigraphyActa Radiologica
researchProduct

Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumab.

2018

Abstract Background Cardiac toxicity with a decrease of the left ventricular ejection fraction (LVEF) is the main side effect induced by trastuzumab. This study reports the fluctuation of LVEF over the 12 months of adjuvant trastuzumab in PHARE trial (NCT00381901). Methods LVEF assessment was performed every 3 months while patients received trastuzumab and after completion of treatment over the first 2 years and then every 6 months afterwards. The fluctuations of LVEF over time were described and a logistic regression model was performed investigating associated factors to LVEF perfect recovery at baseline value. Results A total of 1631 patients who received 12 months of trastuzumab from PH…

Adultmedicine.medical_specialtySide effectReceptor ErbB-2medicine.medical_treatmentBreast Neoplasms030204 cardiovascular system & hematologyVentricular Function Left03 medical and health sciences0302 clinical medicineBreast cancerAntineoplastic Agents ImmunologicalTrastuzumabInternal medicinemedicineHumansIn patientcardiovascular diseasesCardiotoxicityEjection fractionbusiness.industryGeneral MedicineMiddle AgedTrastuzumabmedicine.diseaseCardiotoxicityStandard errorChemotherapy AdjuvantEchocardiography030220 oncology & carcinogenesiscardiovascular systemCardiologySurgeryFemalebusinessAdjuvantcirculatory and respiratory physiologymedicine.drugFollow-Up StudiesBreast (Edinburgh, Scotland)
researchProduct

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study

2007

Abstract Background The objective of this study is to evaluate the efficacy and toxicity of the liposome-encapsulated doxorubicin (TLC D-99) plus cyclophosphamide (CTX) as first-line treatment of metastatic breast cancer in light of the potential cardioprotective effect of TLC D-99 as compared with conventional doxorubicin. Materials and methods Sixty-seven patients as defined according Simon's two-stage phase II design were enrolled. They received TLC D-99 at the dosage of 60 mg/m2 plus CTX 600 mg/m2, with cycles repeated every 3 weeks. Cardiac function was assessed by ultrasonography at baseline and every two cycles. Results The principal characteristics of the 67 enrolled patients were a…

Adultmedicine.medical_specialtySkin NeoplasmsCyclophosphamideSettore MED/06 - Oncologia MedicaPhases of clinical researchBreast NeoplasmsSoft Tissue NeoplasmsAsymptomaticGastroenterologyDrug Delivery SystemsBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineMucositisHumansAntineoplastic Agents AlkylatingCyclophosphamideAgedAntibiotics AntineoplasticPerformance statusbusiness.industryHematologyMiddle Agedmedicine.diseasedoxorubicin cyclophosphamide breast cancerMetastatic breast cancerSurgeryOncologyDoxorubicinLiposomesToxicityCarcinoma Squamous CellFemalemedicine.symptombusinessmedicine.drug
researchProduct

Dermoscopic characteristics of a cutaneous histiocytic sarcoma in a young patient

2017

Adultmedicine.medical_specialtySkin Neoplasmsbusiness.industryJuvenile xanthogranulomaBreast NeoplasmsDermoscopyDermatologyHistiocytic sarcomamedicine.diseaseDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisHumansMedicineFemaleHistiocytic SarcomabusinessHistiocyteJournal of the American Academy of Dermatology
researchProduct

Heavy Resistance Training in Breast Cancer Patients Undergoing Adjuvant Therapy.

2019

BACKGROUND AND PURPOSE Adjuvant breast cancer therapy may reduce maximal muscle strength, muscle mass, and functional performance. Although maximal strength training (MST) has the potential to counteract this debilitating outcome and is shown to be superior to low- and moderate-intensity strength training, it is unknown if it can elicit effective adaptations in patients suffering treatment-induced adverse side effects. METHODS Fifty-five newly diagnosed stage I to III breast cancer patients (49 ± 7 yr) scheduled for adjuvant therapy were randomized to MST or a control group. The MST group performed 4 × 4 repetitions of dynamic leg press at approximately 90% of one-repetition maximum (1RM) t…

Adultmedicine.medical_specialtyStrength trainingmedicine.medical_treatmentUrologyPhysical Therapy Sports Therapy and RehabilitationBreast NeoplasmsWalkingMastectomy SegmentalBody Mass IndexQuadriceps Muscle03 medical and health sciences0302 clinical medicineBreast cancerAdjuvant therapyMedicineHumansOrthopedics and Sports MedicineMuscle StrengthAdverse effectLeg pressbusiness.industryResistance Training030229 sport sciencesMiddle AgedPhysical Functional Performancemedicine.diseaseQuadriceps femoris muscleRadiation therapyLower ExtremityThighChemotherapy AdjuvantFemaleRadiotherapy Adjuvantbusinesshuman activitiesBody mass indexMedicine and science in sports and exercise
researchProduct